Single-centre, single-dose, open-label, randomised, five-way cross-over study to evaluate the pharmacokinetic parameters of intravenously administered combination of paracetamol and ibuprofen, intravenous paracetamol, intravenous ibuprofen and fixed dose combination tablets of paracetamol and ibuprofen, in healthy volunteers

Trial Profile

Single-centre, single-dose, open-label, randomised, five-way cross-over study to evaluate the pharmacokinetic parameters of intravenously administered combination of paracetamol and ibuprofen, intravenous paracetamol, intravenous ibuprofen and fixed dose combination tablets of paracetamol and ibuprofen, in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Ibuprofen/paracetamol (Primary) ; Ibuprofen/paracetamol (Primary) ; Ibuprofen; Paracetamol
  • Indications Postoperative pain
  • Focus Pharmacokinetics
  • Acronyms AFT-MXIV-01
  • Sponsors AFT Pharmaceuticals
  • Most Recent Events

    • 29 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top